|
VOLUME 30: NO. 10 OCTOBER 2003
Editorials
Another DMARD Option in Rheumatoid Arthritis?
 H.A. Capell, R. Madhok .........2085
Clinical Research into Alternative and Complementary Therapies: How Do We Tell
If the Glass Is Half Empty or Half Full?
 D.J. Clauw .........2088
Rheumatic Disease in Han Chinese. What Have We Learned from 19 Years of Epidemiological Study?
 R.D. Wigley .........2090
Where There's Smoke There's Fire: The Silicone
Breast Implant Controversy Continues to Flicker:
A New Disease That Needs To Be Defined
 F.B. Vasey, S.A. Zarabadi, M. Seleznick, L. Ricca .........2092
Articles
Unified Theory of the Origins of Erosive Arthritis: Conditioning as a Protective/Directing Mechanism?
B.M. Rothschild, C. Rothschild, M. Helbling .........2095
Risk Factors for Incident Self-Reported Arthritis in a 20 Year Followup of the Alameda County Study Cohort
W.G. Seavey, J.H. Kurata, R.D. Cohen .........2103
Should Tetracycline Treatment Be Used More Extensively for RA? Metaanalysis Demonstrates Clinical Benefit with Reduction in Disease Activity
M. Stone, P.R. Fortin, C. Pacheco-Tena,
R.D. Inman .........2112
IV Human Recombinant TNFR p55-Fc IgG1 Fusion Protein, Ro 45-2081 (Lenercept): Results of a
Dose-Finding Study in RA
D.E. Furst, M. Weisman,
H.E. Paulus, et al .........2123
Preterm Deliveries in Women with SLE
C.A. Clark, K.A. Spitzer, J.N. Nadler, C.A. Laskin .........2127
Subclinical Disease Activity in SLE: Immunoinflammatory Markers Do Not
Normalize in Clinical Remission
T. Wais, W. Fierz, T. Stoll, P.M. Villiger .........2133
Correlation of Prolactin Serum Concentrations with Clinical Activity and Remission in Patients with SLE. Effect of Conventional Treatment
O. Vera-Lastra, C. Mendez, L.J. Jara, et al .........2140
Cross-Sectional Evaluation of YKL-40 Serum Concentrations in Patients with SSc. Relationship with Clinical and Serological Aspects of Disease
G. La Montagna, S. D'Angelo, G. Valentini .........2147
D6S439 Microsatellite Identifies a New Susceptibility Region for Primary SS
J-M. Anaya, D. Rivera,
L.G. Palacio, M. Arcos-Burgos, P.A. Correa .........2152
Prevalence of Antibodies Against a-Fodrin in SS: Comparison of 2 Sets of Classification Criteria
T. Witte, T. Matthias, M. Oppermann, et al .........2157
Vascular Endothelial Growth Factor Gene Polymorphisms in Giant Cell Arteritis
L. Boiardi, B. Casali, D. Nicoli, et al .........2160
Temporal Arteritis Associated with Systemic Necrotizing Vasculitis
M.A. Hamidou, A. Moreau, C. Toquet, et al .........2165
Contrast Medium in Power Doppler Ultrasound
for Assessment of Synovial Vascularity:
Comparison with Arthroscopy
U. Fiocco, F. Ferro, L. Cozzi, et al .........2170
Duplex Sonography of the Temporal and Occipital Artery in the Diagnosis of Temporal Arteritis.
A Prospective Study
K. Pfadenhauer, H. Weber .........2177
Maternal Age and Family History Are Risk
Factors for AS
F.J. Jiménez-Balderas,
A. Zonana-Nacach, M.L. Sánchez, et al .........2182
Factors Associated with Body Function and Disability in Patients with AS: A Cross-Sectional Study
A. Falkenbach, A. Franke, S. van der Linden .........2186
Differential Effects of FK506 and MTX on Inflammatory Cytokine Levels in Rat Adjuvant-Induced Arthritis
K. Magari, S. Miyata, F. Nishigaki,
Y. Ohkubo, S. Mutoh, T. Goto .........2193
Racial Differences in Health Care Utilization Among Patients with OA
K.L. Dominick, T.K. Dudley,
S.C. Grambow, E.Z. Oddone, H.B. Bosworth .........2201
Expression of the Cartilage Derived Anti-Angiogenic Factor Chondromodulin-I Decreases in the Early Stage of Experimental OA
T. Hayami, H. Funaki, K. Yaoeda, et al .........2207
Measurement of Articular Cartilage Surface Irregularity in Rat Knee Contracture
G. Trudel, K. Himori, L. Goudreau, H.K. Uhthoff .........2218
Rates of Serious GI Events from Low Dose Use of ASA, Acetaminophen, and Ibuprofen in Patients with OA and RA
J.F. Fries, B. Bruce .........2226
The Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with NSAID:
A Multinational Perspective
M. Mockenhaupt, J.P. Kelly, D. Kaufman, R.S. Stern,
and the SCAR Study Group .........2234
Predicting the Risk of GI Bleeding Due to NSAID: NSAID Electronic Assessment of Risk
T.C. Cheetham, G. Levy, M. Spence .........2241
Prevalence of Rheumatic Symptoms, RA, AS, and Gout in Shanghai, China: A COPCORD Study
S-M. Dai, X-H. Han, D-B. Zhao, Y-Q. Shi,
Y. Liu, J-M. Meng .........2245
Prevalence of the Rheumatic Diseases in Urban Vietnam: A WHO-ILAR COPCORD Study
T.T. Minh Hoa, J. Darmawan, C. Shun Le,
N. Van Hung, C. Thi Nhi, T. Ngoc An .........2252
The Efficacy of Mindfulness Meditation Plus Qigong Movement Therapy in the Treatment of FM:
A Randomized Controlled Trial
J.A. Astin, B.M. Berman, B. Bausell, W-L. Lee,
M. Hochberg, K.L. Forys .........2257
Rupture of Silicone Gel Breast Implants and Symptoms of Pain and Fatigue
R.C.W. Vermeulen, H.R. Scholte .........2263
A Comparison of the EuroQol 5D and the Health Utilities Index Mark 3 in Patients with Rheumatic Disease
N. Luo, L-H. Chew, K-Y. Fong, et al .........2268
Pediatric Rheumatology
Incidence of JIA in the Nordic Countries.
A Population Based Study with Special Reference to the Validity of the ILAR and EULAR Criteria
L. Berntson, B. Andersson Gäre, A. Fasth, et al .........2275
Case Reports
Jaw Claudication in Primary Amyloidosis:
Unusual Presentation of a Rare Disease
C.H. Churchill, A. Abril, M. Krishna, M.L. Callman,
W.W. Ginsburg .........2283
Anti-TNF-a Therapy-Induced Vasculitis:
Case Series
S.J. Jarrett, G. Cunnane, P.G. Conaghan, et al .........2287
Images in Rheumatology
Azithromycin-Induced Leukocytoclastic Vasculitis
E. Ödemis, M. Kalyoncu, A. Ökten, K. Yildiz .........2292
Correspondence
HIV-1 and RA: A Puzzling Association
F. Iannone, G. Lapadula .........2294
Reply
J. Wegrzyn, P. Miossec .........2294
Antibody Response to Influenza Immunization
in Patients with SLE
U. Mercado .........2295
Reply M. Abu-Shakra .........2295
Autonomic Involvement in SS
A.J.F. Smith, S.A. Waterman, T.P. Gordon .........2296
Reply
R.K. Niemelä, M. Hakala, H.V. Huikuri,
K.E.J. Airaksinen .........2296
Notices
|